FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W94237140> ?p ?o ?g. }

• W94237140 endingPage "2092" @default.
• W94237140 startingPage "2086" @default.
• W94237140 abstract "Abstract Twenty-six patients with progressive Hodgkin's disease after conventional chemotherapy received intensive chemoradiotherapy and autologous bone marrow transplantation (ABMT); 19 also received additional involved-field radiotherapy. Twenty-one patients [81%, 95% confidence intervals (CI) 61% to 94%] attained complete (n = 18) or partial responses. Ten patients (38%, 95% CI 20% to 59%) are disease- free a median of 4.5 years later (range 3.5 to 7.0 years), including seven patients with continuous complete responses. The likelihood of overall response was not significantly influenced by any clinical or treatment variable examined. However, there was a trend favoring patients with higher Karnofsky scores, and higher scores were associated with attainment of complete responses (P = .06 and P = .02, respectively, Mann-Whitney U test). Both higher Karnofsky scores and shorter durations of disease before transplantation were associated with improved survival in a stepwise Cox multivariate analysis. The chief cause of failure was progression at sites previously involved with Hodgkin's disease. No patient relapsed in the marrow, and two of three patients with a history of marrow involvement with Hodgkin's disease achieved durable complete responses after transplantation. These data suggest that inadequate pretransplant conditioning, and not the reinoculation of occult tumor cells in the autologous marrow, caused most relapses. Fatal treatment-related toxicity occurred in six patients. Three patients died of idiopathic interstitial pneumonitis; each had previously received local mediastinal irradiation before intensive chemoradiotherapy. Intensive chemoradiotherapy and ABMT produces durable responses in some patients with Hodgkin's disease incurable with conventional therapy. Use of such therapies at the first sign of failure with conventional chemotherapy and development of more effective conditioning regimens should further improve results." @default.
• W94237140 created "2016-06-24" @default.
• W94237140 creator A5002827227 @default.
• W94237140 creator A5011201747 @default.
• W94237140 creator A5011576328 @default.
• W94237140 creator A5014443770 @default.
• W94237140 creator A5021021145 @default.
• W94237140 creator A5035700599 @default.
• W94237140 creator A5043776688 @default.
• W94237140 creator A5048988641 @default.
• W94237140 creator A5060069903 @default.
• W94237140 creator A5091344614 @default.
• W94237140 date "1989-06-01" @default.
• W94237140 modified "2023-10-09" @default.
• W94237140 title "Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation" @default.
• W94237140 cites W1495776442 @default.
• W94237140 cites W1527933360 @default.
• W94237140 cites W1580788756 @default.
• W94237140 cites W1808994586 @default.
• W94237140 cites W1822014629 @default.
• W94237140 cites W1972978214 @default.
• W94237140 cites W1979300931 @default.
• W94237140 cites W1985883917 @default.
• W94237140 cites W1986553601 @default.
• W94237140 cites W1987759419 @default.
• W94237140 cites W2024712996 @default.
• W94237140 cites W2055310422 @default.
• W94237140 cites W2064061092 @default.
• W94237140 cites W2065408685 @default.
• W94237140 cites W2071060238 @default.
• W94237140 cites W2072488042 @default.
• W94237140 cites W2075898541 @default.
• W94237140 cites W2083616014 @default.
• W94237140 cites W2084886561 @default.
• W94237140 cites W2093076886 @default.
• W94237140 cites W2156906636 @default.
• W94237140 cites W2187668060 @default.
• W94237140 cites W2253815627 @default.
• W94237140 cites W2255041800 @default.
• W94237140 cites W2268988027 @default.
• W94237140 cites W2313423582 @default.
• W94237140 cites W2328846480 @default.
• W94237140 cites W2339709756 @default.
• W94237140 cites W2416197813 @default.
• W94237140 cites W2469334233 @default.
• W94237140 cites W5387557 @default.
• W94237140 cites W58756698 @default.
• W94237140 cites W2036330294 @default.
• W94237140 doi "https://doi.org/10.1182/blood.v73.8.2086.2086" @default.
• W94237140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2659100" @default.
• W94237140 hasPublicationYear "1989" @default.
• W94237140 type Work @default.
• W94237140 sameAs 94237140 @default.
• W94237140 citedByCount "168" @default.
• W94237140 countsByYear W942371402012 @default.
• W94237140 countsByYear W942371402013 @default.
• W94237140 countsByYear W942371402015 @default.
• W94237140 countsByYear W942371402016 @default.
• W94237140 countsByYear W942371402017 @default.
• W94237140 countsByYear W942371402018 @default.
• W94237140 countsByYear W942371402019 @default.
• W94237140 countsByYear W942371402020 @default.
• W94237140 countsByYear W942371402022 @default.
• W94237140 countsByYear W942371402023 @default.
• W94237140 crossrefType "journal-article" @default.
• W94237140 hasAuthorship W94237140A5002827227 @default.
• W94237140 hasAuthorship W94237140A5011201747 @default.
• W94237140 hasAuthorship W94237140A5011576328 @default.
• W94237140 hasAuthorship W94237140A5014443770 @default.
• W94237140 hasAuthorship W94237140A5021021145 @default.
• W94237140 hasAuthorship W94237140A5035700599 @default.
• W94237140 hasAuthorship W94237140A5043776688 @default.
• W94237140 hasAuthorship W94237140A5048988641 @default.
• W94237140 hasAuthorship W94237140A5060069903 @default.
• W94237140 hasAuthorship W94237140A5091344614 @default.
• W94237140 hasBestOaLocation W942371401 @default.
• W94237140 hasConcept C126322002 @default.
• W94237140 hasConcept C141071460 @default.
• W94237140 hasConcept C2776694085 @default.
• W94237140 hasConcept C2778424827 @default.
• W94237140 hasConcept C2778822529 @default.
• W94237140 hasConcept C2911091166 @default.
• W94237140 hasConcept C509974204 @default.
• W94237140 hasConcept C71924100 @default.
• W94237140 hasConceptScore W94237140C126322002 @default.
• W94237140 hasConceptScore W94237140C141071460 @default.
• W94237140 hasConceptScore W94237140C2776694085 @default.
• W94237140 hasConceptScore W94237140C2778424827 @default.
• W94237140 hasConceptScore W94237140C2778822529 @default.
• W94237140 hasConceptScore W94237140C2911091166 @default.
• W94237140 hasConceptScore W94237140C509974204 @default.
• W94237140 hasConceptScore W94237140C71924100 @default.
• W94237140 hasIssue "8" @default.
• W94237140 hasLocation W942371401 @default.
• W94237140 hasOpenAccess W94237140 @default.
• W94237140 hasPrimaryLocation W942371401 @default.
• W94237140 hasRelatedWork W2089609493 @default.
• W94237140 hasRelatedWork W2347438058 @default.

• next